Ashish M. Kamat, MD, MBBS
@urodocash
Endowed Professor, Surgeon, Former Fellowship Director @MDAndersonNews | President, IBCG | Assoc Editor @EurUrolOncol | Views my own
ID: 124649482
http://faculty.mdanderson.org/Ashish_Kamat/Default.asp 20-03-2010 03:23:48
8,8K Tweet
10,10K Followers
768 Following
Thanks Ashish M. Kamat, MD, MBBS for an amazing IBCG 2nd #IBCG24 Honored to to co-chair w/Roger Li Patrick Hensley, MD Loved the discussions from 🌎experts including pt. advocates. Wes Kassouf Sia Daneshmand, M.D. Philippe spiess Andrea Necchi Jonathan Rosenberg MD Karima Oualla, MD,MSc Petros Grivas
Amir is being modest, as always Horowitz Lab @Icahn School of Medicine Mount Sinai lab work will be instrumental in propelling the field of BCG immunology forward exponentially
Congrats to Ashish M. Kamat, MD, MBBS Roger Li Patrick Hensley, MD Shilpa Gupta for organizing a phenomenal IBCG 2024 meeting at Houston. It was nice to catch up with friends from around the 🌎 and grateful for the opportunity to contribute to discussions to improve #bladdercancer care!
⚡️ On European Urology - Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection #BladderCancer Ashish M. Kamat, MD, MBBS sciencedirect.com/science/articl…
🚀 Exciting Opportunity! MD Anderson Cancer Center is seeking a visionary leader to chair the Genitourinary Radiation Oncology department. Lead a team driving innovation with cutting-edge technologies & advance the future of cancer care. Apply here by Sept 15! jobs.mdanderson.org/search/jobdeta…
This is a major announcement! Congratulations Tom Powles and team, and especially patients everywhere World Bladder Cancer Patient Coalition Bladder Cancer Advocacy Network IBCG
Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma. What is most important to patients regarding their experiences of disease burden and treatment #BladderCancer Nicholas Simon link.springer.com/article/10.100…
Managing variant histology in high-risk non-muscle invasive #BladderCancer. Cookson, Michael University of Oklahoma Urology & Paolo Gontero MolinetteUrology discuss with Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center as part of the IBCG #BladderCancerForum > bit.ly/3xyeyRr
Guidelines aim to harmonize and optimize urothelial carcinoma clinical trials. Ashish M. Kamat, MD, MBBS and Matt Galsky join Sam S. Chang MD, MBA to discuss new trial parameters and the urgent need for detailed guidelines due to the dynamic landscape of treatment > bit.ly/4bcYVxh
Understanding BCG unresponsive #NMIBC: Patient perspectives, treatment options, and clinical guidance. Tom Jayram Urology Associates joins Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center to discuss the complexities of BCG unresponsiveness in bladder cancer treatment. #WatchNow > bit.ly/3y0qKdp
Ashish M. Kamat, MD, MBBS and Shilpa Gupta discuss the best of #ASCO24 in advanced #BladderCancer. Highlights include: improved outcomes in lymph node-only metastatic disease in #CheckMate-901, enhanced survival and QoL with EV + pembro in EV-302, and #KEYNOTE-361 > bit.ly/3MxzRWU